Press Releases

News

Roswell Park Surgeons Compile New Anthology on Surgery for Stomach, Esophageal Cancers

Two Roswell Park Cancer Institute surgeons have produced a new, comprehensive guide on minimally invasive surgical approaches for treating cancers of the stomach and esophagus. Published by Springer, the anthology, “Minimally Invasive Foregut Surgery for Malignancy: Principles and Practice,” was edited by Steven Hochwald, MD, FACS, Chief of Gastrointestinal Surgery and Vice Chair of the Department of Surgical Oncology, and Moshim Kukar, MD, a newly appointed faculty member in the RPCI Department of Surgical Oncology.
News

Roswell Park Study Suggests Additional Applications for FL118 as Personalized Therapy for Cancer

A team led by Fengzhi Li, PhD, and Xinjiang Wang, PhD, of Roswell Park Cancer Institute has reported new findings regarding therapeutic targets of the novel anticancer agent FL118. Previous studies from these researchers have showed that FL118 induces cancer cell death, or apoptosis, by inhibiting expression of multiple cell-survival proteins (survivin, Mcl-1, XIAP or cIAP2).
News

Dr. Boris Kuvshinoff Named Chief Medical Quality Officer, Interim Chief Medical Officer at Roswell Park

Boris Kuvshinoff II, MD, MBA, has been named Chief Medical Quality Officer and interim Chief Medical Officer at Roswell Park Comprehensive Cancer Center. A surgical oncologist and longtime clinical and faculty leader at the comprehensive cancer center, he will provide day-to-day leadership and management of Roswell Park’s quality strategy, encompassing responsibilities in the areas of clinical performance improvement and patient safety, risk management, medical staff affairs and development of Institute policies.

News

Roswell Park’s OmniSeq Target Panel Discussion Dec. 2 to Inform Public About Groundbreaking Diagnostic Test

n July, Roswell Park Comprehensive Cancere Center received approval from the New York State Department of Health to begin genomic testing of cancer patients using an advanced molecular diagnostic laboratory test developed by the Roswell Park Center for Personalized Medicine. Now, the same experts who led the development and clinical implementation of that groundbreaking tool, OmniSeq Target™, are conducting a public forum to help families affected by cancer understand how this new approach is changing the face of cancer diagnosis and treatment.
News

New Roswell Park Endoscopy Center is First of its Kind in Region

At a ribbon-cutting ceremony today, Roswell Park Comprehensive Cancer Center unveiled a new Endoscopy Center, a multipurpose clinical space that brings together advanced endoscopy and interventional pulmonology services into one state-of-the-art facility. The new center, designed for optimal patient safety and comfort, was built to meet increasing demand for minimally invasive endoscopic procedures used for diagnosis, staging and treatment of malignant and nonmalignant gastrointestinal and pulmonary conditions.